Work

Activity of insulin growth factor-receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic refractory adrenocortical carcinoma.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.4639

Authors: Aung Naing, Patricia LoRusso, Siqing Fu, David S. Hong, Helen Chen, L. Austin Doyle, Alexandria Phan, Mouhammed Amir Habra, Razelle Kurzrock

Institutions: The University of Texas MD Anderson Cancer Center, The Barbara Ann Karmanos Cancer Institute, National Institutes of Health, National Cancer Institute

Language: English

Topic: Adrenal and Paraganglionic Tumors

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601893961

Cites:

Cited by:

Related to: 10